Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2: A High-Throughput Method for the Evaluation of Vaccine Immunogenicity

Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2: A High-Throughput Method for the Evaluation of Vaccine Immunogenicity

The evaluation of coronavirus disease 2019 (COVID-19) vaccine immunogenicity remains essential as the severe acute respiratory syncytial virus 2 (SARS-CoV-2) pandemic continues to evolve and as additional variants emerge. Neutralizing antibodies are a known correlate of protection for SARS-CoV-2 vac...

Full description

Bibliographic Details
Main Authors: Zhaohui Cai, Raj Kalkeri, Mi Wang, Benjamin Haner, Dominic Dent, Bahar Osman, Paul Skonieczny, Jeremy Ross, Sheau-Line Feng, Rongman Cai, Mingzhu Zhu, Shane Cloney-Clark, Joyce S. Plested
Format: Article
Language:English
Published: MDPI AG 2024-06-01
Series:Microorganisms
Subjects:
neutralization
pseudovirus
COVID-19
Omicron variant
emerging variants
XBB variants
Online Access:https://www.mdpi.com/2076-2607/12/6/1201

Internet

https://www.mdpi.com/2076-2607/12/6/1201

Similar Items